08:00 , Nov 9, 2009 |  BC Week In Review  |  Company News

Algonomics, Lonza Group AG deal

Lonza acquired CRO AlgoNomics for an undisclosed sum. The deal gives Lonza Algonomics' Epibase and Epibase IV immunogenicity screening technologies and Tripole, a protein remodeling bioinformatics technology. Algonomics N.V. , Ghent, Belgium   Lonza Group...
08:00 , Mar 5, 2009 |  BC Innovations  |  Cover Story

Anti-flubodies

Two separate teams have isolated human antibodies that neutralize many variants of influenza antigen hemagglutinin A and prevent viral entry and infection. Both teams are developing their antibodies as therapeutics but are going after different...
08:00 , Feb 2, 2009 |  BC Week In Review  |  Company News

Algonomics, International AIDS Vaccine Initiative deal

The partners will modify regions in the HIV gag protein to increase immune response to candidate vaccines. AlgoNomics will use its Epibase technology to identify T cell epitopes of the HIV gag protein and test...
08:00 , Feb 11, 2008 |  BC Week In Review  |  Company News

Algonomics, Genmab deal

AlgoNomics will use its antibody structure database and Tripole protein modeling technology to assist in the structural analysis of Genmab's antibody scaffolds, including its UniBody technology. AlgoNomics is eligible for research funding and milestone payments....
08:00 , Dec 24, 2007 |  BC Week In Review  |  Company News

Algonomics management update

AlgoNomics N.V. , Ghent, Belgium   Business: Bioinformatics   Promoted: Philippe Stas to CEO from COO, he replaces Ignace Lasters, who will become CSO and a director  ...
07:00 , May 7, 2007 |  BC Week In Review  |  Company News

Algonomics, Itochu Corp. sales and marketing update

Itochu's CTC Laboratory Systems Corp. subsidiary received exclusive rights to market AlgoNomics' Epibase in silico immunogenicity screening technology in Japan. Financial terms were not disclosed. AlgoNomics N.V. , Ghent, Belgium   Itochu Corp. (Tokyo:8001), Tokyo,...
08:00 , Dec 18, 2006 |  BC Week In Review  |  Company News

Algonomics, Flanders Interuniversity Institute for Biotechnology deal

The institute will provide AlgoNomics with an in vitro test to supplement the company's Epibase in silico test to verify whether certain proteins induce an immune response in humans. AlgoNomics will be responsible for developing...
07:00 , Oct 16, 2006 |  BC Week In Review  |  Company News

Algonomics, Alligator Bioscience deal

AlgoNomics will use its Epibase immunoprofiling technology to analyze the immunogenicity of therapeutic proteins in Alligator's internal and collaborative projects. Financial terms and therapeutic focus were not disclosed. AlgoNomics N.V. , Ghent, Belgium   Alligator...
07:00 , Jun 19, 2006 |  BC Week In Review  |  Company News

Algonomics, MAT Biopharma deal

AlgoNomics will use its structural bioinformatics technology to help analyze the structure and immunogenicity of MAT's cancer antibodies. Further terms were not disclosed. AlgoNomics N.V. , Ghent, Belgium   MAT Biopharma S.A. , Evry, France...
07:00 , May 16, 2005 |  BC Week In Review  |  Company News

Algonomics, Genmab deal

AlgoNomics granted GEN access to its Epibase technology for T cell epitope identification. Financial terms were not disclosed. AlgoNomics N.V. , Ghent, Belgium   Genmab A/S (CSE:GEN), Copenhagen, Denmark   Business: Antibodies  ...